Global and China IBS-C Drug Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the IBS-C Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Catalent Pharmaceuticals Solutions

    • Astellas Pharmaceuticals

    • The Menarini Group

    • Ardelyx

    • Prometheus Laboratories

    • Ironwood Pharmaceuticals

    • Bama-Geve

    • Albireo Pharma

    • Teva Pharmaceutical Industries

    • Salix Pharmaceuticals

    • Ferring BV

    • Ono Pharmaceutical

    • Abbott Laboratories

    • Novartis Pharma

    • Synthetic Biologics

    • Sucampo Pharmaceuticals

    • Actavis Nordic

    • Synergy Pharmaceuticals

    • Astrazeneca

    • Nestle

    • Yuhan Corp

    • Norgine

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Linaclotide

    • Lubiprostone

    • Osmotic Laxatives

    • Stimulant Laxatives

    • Other

    Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 IBS-C Drug Industry Overview

      • 1.1.1 IBS-C Drug Market Scope and Market Segments

      • 1.1.2 IBS-C Drug Industry Characteristics

      • 1.1.3 Global and China IBS-C Drug Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China IBS-C Drug Production Value and Growth Rate (2017-2028)

    • 1.2 Global IBS-C Drug Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Linaclotide

      • 1.2.2 Lubiprostone

      • 1.2.3 Osmotic Laxatives

      • 1.2.4 Stimulant Laxatives

      • 1.2.5 Other

    • 1.3 Global IBS-C Drug Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Retail Pharmacies

      • 1.3.3 Online Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America IBS-C Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe IBS-C Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC IBS-C Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa IBS-C Drug Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global IBS-C Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global IBS-C Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China IBS-C Drug Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China IBS-C Drug Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global IBS-C Drug Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 IBS-C Drug Industry Porter's Five Forces Model Analysis

      • 2.2.3 IBS-C Drug Industry PEST Analysis

    • 2.3 IBS-C Drug Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 IBS-C Drug Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on IBS-C Drug Industry

    Chapter 3 Global and China IBS-C Drug Market, by Manufacturer

    • 3.1 Global and China IBS-C Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China IBS-C Drug Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China IBS-C Drug Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China IBS-C Drug Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China IBS-C Drug Market Top 3 Players

    Chapter 4 Global and China IBS-C Drug Market, by Type (2017-2028)

    • 4.1 IBS-C Drug Market Trend, by Type

    • 4.2 Global IBS-C Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global IBS-C Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global IBS-C Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global IBS-C Drug Price Trend, by Type (2017-2028)

    • 4.3 China IBS-C Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China IBS-C Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China IBS-C Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China IBS-C Drug Price Trend, by Type (2017-2028)

    Chapter 5 Global and China IBS-C Drug Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global IBS-C Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global IBS-C Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global IBS-C Drug Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China IBS-C Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China IBS-C Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China IBS-C Drug Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global IBS-C Drug Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China IBS-C Drug Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America IBS-C Drug Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe IBS-C Drug Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC IBS-C Drug Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa IBS-C Drug Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America IBS-C Drug Market Analysis

    • 7.1 North America IBS-C Drug Market, by Type

    • 7.2 North America IBS-C Drug Market, by Application

    • 7.3 North America IBS-C Drug Market Analysis and Forecast, by Country

      • 7.3.1 United States IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe IBS-C Drug Market Analysis

    • 8.1 Europe IBS-C Drug Market, by Type

    • 8.2 Europe IBS-C Drug Market, by Application

    • 8.3 Europe IBS-C Drug Market Analysis and Forecast, by Country

      • 8.3.1 Germany IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC IBS-C Drug Market Analysis

    • 9.1 APAC IBS-C Drug Market, by Type

    • 9.2 APAC IBS-C Drug Market, by Application

    • 9.3 APAC IBS-C Drug Market Analysis and Forecast, by Country

      • 9.3.1 China IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa IBS-C Drug Market Analysis

    • 10.1 Latin America, Middle East and Africa IBS-C Drug Market, by Type

    • 10.2 Latin America, Middle East and Africa IBS-C Drug Market, by Application

    • 10.3 Latin America, Middle East and Africa IBS-C Drug Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina IBS-C Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China IBS-C Drug Company Profiles

      • 11.1 Catalent Pharmaceuticals Solutions

        • 11.1.1 Catalent Pharmaceuticals Solutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Catalent Pharmaceuticals Solutions IBS-C Drug Product Profiles, Application and Specification

        • 11.1.3 Catalent Pharmaceuticals Solutions IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Astellas Pharmaceuticals

        • 11.2.1 Astellas Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Astellas Pharmaceuticals IBS-C Drug Product Profiles, Application and Specification

        • 11.2.3 Astellas Pharmaceuticals IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 The Menarini Group

        • 11.3.1 The Menarini Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 The Menarini Group IBS-C Drug Product Profiles, Application and Specification

        • 11.3.3 The Menarini Group IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Ardelyx

        • 11.4.1 Ardelyx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Ardelyx IBS-C Drug Product Profiles, Application and Specification

        • 11.4.3 Ardelyx IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Prometheus Laboratories

        • 11.5.1 Prometheus Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Prometheus Laboratories IBS-C Drug Product Profiles, Application and Specification

        • 11.5.3 Prometheus Laboratories IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Ironwood Pharmaceuticals

        • 11.6.1 Ironwood Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Ironwood Pharmaceuticals IBS-C Drug Product Profiles, Application and Specification

        • 11.6.3 Ironwood Pharmaceuticals IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Bama-Geve

        • 11.7.1 Bama-Geve Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Bama-Geve IBS-C Drug Product Profiles, Application and Specification

        • 11.7.3 Bama-Geve IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Albireo Pharma

        • 11.8.1 Albireo Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Albireo Pharma IBS-C Drug Product Profiles, Application and Specification

        • 11.8.3 Albireo Pharma IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Teva Pharmaceutical Industries

        • 11.9.1 Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Teva Pharmaceutical Industries IBS-C Drug Product Profiles, Application and Specification

        • 11.9.3 Teva Pharmaceutical Industries IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Salix Pharmaceuticals

        • 11.10.1 Salix Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Salix Pharmaceuticals IBS-C Drug Product Profiles, Application and Specification

        • 11.10.3 Salix Pharmaceuticals IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Ferring BV

        • 11.11.1 Ferring BV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Ferring BV IBS-C Drug Product Profiles, Application and Specification

        • 11.11.3 Ferring BV IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Ono Pharmaceutical

        • 11.12.1 Ono Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Ono Pharmaceutical IBS-C Drug Product Profiles, Application and Specification

        • 11.12.3 Ono Pharmaceutical IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Abbott Laboratories

        • 11.13.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Abbott Laboratories IBS-C Drug Product Profiles, Application and Specification

        • 11.13.3 Abbott Laboratories IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Novartis Pharma

        • 11.14.1 Novartis Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Novartis Pharma IBS-C Drug Product Profiles, Application and Specification

        • 11.14.3 Novartis Pharma IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Synthetic Biologics

        • 11.15.1 Synthetic Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Synthetic Biologics IBS-C Drug Product Profiles, Application and Specification

        • 11.15.3 Synthetic Biologics IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Sucampo Pharmaceuticals

        • 11.16.1 Sucampo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Sucampo Pharmaceuticals IBS-C Drug Product Profiles, Application and Specification

        • 11.16.3 Sucampo Pharmaceuticals IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Actavis Nordic

        • 11.17.1 Actavis Nordic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Actavis Nordic IBS-C Drug Product Profiles, Application and Specification

        • 11.17.3 Actavis Nordic IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Synergy Pharmaceuticals

        • 11.18.1 Synergy Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Synergy Pharmaceuticals IBS-C Drug Product Profiles, Application and Specification

        • 11.18.3 Synergy Pharmaceuticals IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Astrazeneca

        • 11.19.1 Astrazeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Astrazeneca IBS-C Drug Product Profiles, Application and Specification

        • 11.19.3 Astrazeneca IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Nestle

        • 11.20.1 Nestle Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Nestle IBS-C Drug Product Profiles, Application and Specification

        • 11.20.3 Nestle IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Yuhan Corp

        • 11.21.1 Yuhan Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Yuhan Corp IBS-C Drug Product Profiles, Application and Specification

        • 11.21.3 Yuhan Corp IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 Norgine

        • 11.22.1 Norgine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 Norgine IBS-C Drug Product Profiles, Application and Specification

        • 11.22.3 Norgine IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 IBS-C Drug Industry Investment Prospect and Risk Assessment

    • 12.1 IBS-C Drug Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 IBS-C Drug Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Global IBS-C Drug Production Value and Growth Rate (2017-2028)

    • Figure China IBS-C Drug Production Value and Growth Rate (2017-2028)

    • Figure Global IBS-C Drug Market Size and Growth Rate of Linaclotide (2017-2028)

    • Figure Global IBS-C Drug Market Size and Growth Rate of Lubiprostone (2017-2028)

    • Figure Global IBS-C Drug Market Size and Growth Rate of Osmotic Laxatives (2017-2028)

    • Figure Global IBS-C Drug Market Size and Growth Rate of Stimulant Laxatives (2017-2028)

    • Figure Global IBS-C Drug Market Size and Growth Rate of Other (2017-2028)

    • Figure Global IBS-C Drug Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global IBS-C Drug Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure Global IBS-C Drug Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure North America IBS-C Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe IBS-C Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC IBS-C Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa IBS-C Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global IBS-C Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China IBS-C Drug Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China IBS-C Drug Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China IBS-C Drug Sales Value, by Manufacturer (2021&2022)

    • Table Global and China IBS-C Drug Market Share, by Manufacturer (2021&2022)

    • Figure Global and China IBS-C Drug Market Share, by Manufacturer in 2021

    • Figure Global and China IBS-C Drug Market Share, by Manufacturer in 2022

    • Table Global IBS-C Drug Sales Volume, by Type (2017-2028)

    • Table Global IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Figure Global IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Table Global IBS-C Drug Sales Value, by Type (2017-2028)

    • Table Global IBS-C Drug Sales Value Share, by Type (2017-2028)

    • Figure Global IBS-C Drug Price Trend, by Type (2017-2028)

    • Table China IBS-C Drug Sales Volume, by Type (2017-2028)

    • Table China IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Figure China IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Table China IBS-C Drug Sales Value, by Type (2017-2028)

    • Table China IBS-C Drug Sales Value Share, by Type (2017-2028)

    • Figure China IBS-C Drug Price Trend, by Type (2017-2028)

    • Table Global IBS-C Drug Sales Volume, by Application (2017-2028)

    • Table Global IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Figure Global IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Table Global IBS-C Drug Sales Value, by Application (2017-2028)

    • Table Global IBS-C Drug Sales Value Share, by Application (2017-2028)

    • Figure Global IBS-C Drug Sales Value Share, by Application (2017-2028)

    • Table China IBS-C Drug Sales Volume, by Application (2017-2028)

    • Table China IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Figure China IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Table China IBS-C Drug Sales Value, by Application (2017-2028)

    • Table China IBS-C Drug Sales Value Share, by Application (2017-2028)

    • Figure China IBS-C Drug Sales Value Share, by Application (2017-2028)

    • Figure China IBS-C Drug Production, Import, Consumption and Export (2017-2022)

    • Figure North America IBS-C Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Europe IBS-C Drug Production, Import, Consumption and Export (2017-2022)

    • Figure APAC IBS-C Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa IBS-C Drug Production, Import, Consumption and Export (2017-2022)

    • Table North America IBS-C Drug Sales Volume, by Type (2017-2028)

    • Table North America IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Figure North America IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Table North America IBS-C Drug Sales Volume, by Application (2017-2028)

    • Table North America IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Figure North America IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Figure United States IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure United States IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Canada IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Canada IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Mexico IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Table Europe IBS-C Drug Sales Volume, by Type (2017-2028)

    • Table Europe IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Figure Europe IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Table Europe IBS-C Drug Sales Volume, by Application (2017-2028)

    • Table Europe IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Figure Europe IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Figure Germany IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Germany IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure UK IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure UK IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure France IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure France IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Italy IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Italy IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Spain IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Spain IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Belgium IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Poland IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Poland IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Russia IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Russia IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Turkey IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Table APAC IBS-C Drug Sales Volume, by Type (2017-2028)

    • Table APAC IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Figure APAC IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Table APAC IBS-C Drug Sales Volume, by Application (2017-2028)

    • Table APAC IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Figure APAC IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Figure China IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Japan IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Japan IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure India IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure India IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Korea IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa IBS-C Drug Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa IBS-C Drug Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa IBS-C Drug Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa IBS-C Drug Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Brazil IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Africa IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Figure Argentina IBS-C Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina IBS-C Drug Sales Value and Growth Rate (2017-2028)

    • Table Catalent Pharmaceuticals Solutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Catalent Pharmaceuticals Solutions Product Profiles, Application and Specification

    • Table Catalent Pharmaceuticals Solutions IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharmaceuticals Product Profiles, Application and Specification

    • Table Astellas Pharmaceuticals IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table The Menarini Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table The Menarini Group Product Profiles, Application and Specification

    • Table The Menarini Group IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ardelyx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ardelyx Product Profiles, Application and Specification

    • Table Ardelyx IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Prometheus Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Prometheus Laboratories Product Profiles, Application and Specification

    • Table Prometheus Laboratories IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ironwood Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ironwood Pharmaceuticals Product Profiles, Application and Specification

    • Table Ironwood Pharmaceuticals IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bama-Geve Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bama-Geve Product Profiles, Application and Specification

    • Table Bama-Geve IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Albireo Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Albireo Pharma Product Profiles, Application and Specification

    • Table Albireo Pharma IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Industries Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Industries IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Salix Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Salix Pharmaceuticals Product Profiles, Application and Specification

    • Table Salix Pharmaceuticals IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ferring BV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ferring BV Product Profiles, Application and Specification

    • Table Ferring BV IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ono Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ono Pharmaceutical Product Profiles, Application and Specification

    • Table Ono Pharmaceutical IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Pharma Product Profiles, Application and Specification

    • Table Novartis Pharma IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Synthetic Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Synthetic Biologics Product Profiles, Application and Specification

    • Table Synthetic Biologics IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sucampo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sucampo Pharmaceuticals Product Profiles, Application and Specification

    • Table Sucampo Pharmaceuticals IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Actavis Nordic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Actavis Nordic Product Profiles, Application and Specification

    • Table Actavis Nordic IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Synergy Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Synergy Pharmaceuticals Product Profiles, Application and Specification

    • Table Synergy Pharmaceuticals IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astrazeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astrazeneca Product Profiles, Application and Specification

    • Table Astrazeneca IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nestle Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nestle Product Profiles, Application and Specification

    • Table Nestle IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Yuhan Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Yuhan Corp Product Profiles, Application and Specification

    • Table Yuhan Corp IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Norgine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Norgine Product Profiles, Application and Specification

    • Table Norgine IBS-C Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.